Neural and Hormonal Influences on Alcohol Use Disorder Risk
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you have medical or psychiatric conditions that require medication where alcohol is not allowed.
What evidence supports the effectiveness of the treatment 'Neural and Hormonal Influences on Sex Differences in Risk for AUD'?
Research suggests that sex hormones like testosterone and estrogen play a role in alcohol use and addiction, with testosterone linked to higher alcohol use in males and estrogen linked to higher use in females. Understanding these hormonal influences could help develop targeted treatments for alcohol use disorder (AUD) based on sex differences.12345
Is the treatment generally safe for humans?
How does the treatment 'Neural and Hormonal Influences on Sex Differences in Risk for AUD' differ from other treatments for alcohol use disorder?
This treatment is unique because it focuses on the role of sex hormones and their influence on brain structure and function, which may contribute to differences in alcohol use disorder risk between males and females. It considers both the permanent and temporary effects of sex hormones on the brain, potentially offering a novel approach to understanding and treating alcohol addiction by targeting these hormonal influences.12345
What is the purpose of this trial?
The sex gap in alcohol consumption is closing rapidly, due to alarming increases among women. From 2002-2013, Alcohol Use Disorder (AUD) increased 84% for women, compared to 35% for men. As such, there is an urgent need to determine the factors underlying sex differences in risk for AUD. Current addiction models propose three domains that drive problematic alcohol use and serve as candidate sex-specific risk factors: executive function, negative emotionality, and incentive salience. Data suggest that poor inhibitory control, a key component of executive function, is a stronger risk factor for women than for men. Moreover, there is have preliminary evidence that female drinkers show less engagement of neural inhibitory circuitry, and that this sex difference is influenced by estradiol. However, the degree to which hormonally-moderated sex differences in executive function extend to the negative emotionality and incentive salience domains, and how these sex differences influence current and future drinking is unknown.The goal of this study is to identify the mechanisms underlying sex-specific risk for AUD, and ultimately to help develop sex-specific prevention and treatment efforts. The overall objective of this trial is to determine the neural and hormonal factors contributing to sex-specific risk for AUD in three addiction domains: inhibitory control (executive function), negative emotionality, and alcohol cue reactivity (incentive salience).
Research Team
Jessica Weafer, PhD
Principal Investigator
Ohio State University
Eligibility Criteria
This trial is for English-speaking, right-handed individuals with at least a high school education who regularly consume alcohol. Women must have regular menstrual cycles and not be pregnant, nursing, or on hormonal contraception. Participants should weigh between 110 and 210 lbs and not require medication that interacts badly with alcohol.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessments including neural inhibitory function, negative emotionality, and alcohol cue reactivity tasks
Experimental Sessions
Participants engage in tasks such as the stop signal task, Emotional Pictures Task, and Alcohol Cue Reactivity Task to measure neural responses
Follow-up
Participants are monitored for prospective alcohol consumption and self-reported current alcohol consumption
Treatment Details
Interventions
- Neural and Hormonal Influences on Sex Differences in Risk for AUD
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jessica Weafer
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator